Zinacef Articles
Diapharm organizes GMP inspection at Ranbaxy
13 May 2009
Orchid Chemicals gets US approval for cefuroxime
27 October 2008
PhRMA details Mexico flood relief by members
17 December 2007
First fine for "predatory pricing" in France for GSK
26 March 2007
2nd-qtr exports slide at Indian drugmakers
15 November 2004
Indian firms pay high cost for generics
12 July 2004
Ranbaxy reports cefuroxime case win
19 April 2004
Bayer's Avelox superior in AECB
15 March 2004
Ranbaxy reports 2003 global sales up 22%
9 February 2004
IVAX applies to FDA for generic Lexapro
18 August 2003
US federal court upholds GSK's Ceftin patent
12 May 2003
GSK wins protection for Ceftin antibiotic
12 May 2003
Stock Commentary - Europe
12 May 2003
Update: GSK 2002 results boosted by 13% growth in US sales
17 February 2003
GlaxoSmithKline 2002 results boosted by 13% growth in US sales
17 February 2003
Ranbaxy 4th-qtr net profit rockets 323%
27 January 2003
Ranbaxy gets US OK for generic Ceftin
25 February 2002
Ranbaxy full-year 2001 sales up 22.9%
4 February 2002
Ranbaxy to receive FDA OK for controversial antibiotic?
11 October 2001
Ranbaxy 1st-quarter profits rise 47%
4 May 2001
Ranbaxy selling 50% JV stake to Lilly
19 January 2001
Aventis reveals first Phase III Ketek data at ICAAC, sees $1 billion in
28 September 2000
Aventis reveals first Phase III Ketek data at ICAAC
20 September 2000
China sees over-supply, low demand for drugs
16 March 2000
Glaxo SmithKline, an R&D powerhouse and global number one
17 January 2000
First approval for B-MS' Tequin heats up antibiotic sector - update
30 December 1999
GW withdraws Raxar on safety concerns
28 October 1999
New US CDC otitis media treatment guidelines
26 January 1999
Greece To Slim Official Drug List
4 February 1998
FDA Year-End Approval Spate As Expected
6 January 1997
Glaxo Wellcome Licences Otsuka's Grepafloeacin
10 June 1996
Disease ManagementThe Way Forward
15 May 1995
Glaxo Interim Profits Up 10% On 2% Sales Rise
13 February 1995
Competition and Acquisition Pressure Hits Glaxo
19 September 1994
GLAXO LAUNCH IN FRANCE
4 July 1994
FIRST CLINICAL DATA FOR GLAXO'S GR122311X
6 June 1994
GENERIC DRUGS AND DELIVERY SYSTEMS
18 April 1994
US PRODUCT NEWS IN BRIEF
18 April 1994
STRONG PERFORMANCE FROM GLAXO, AND ZANTAC
13 September 1993
CEFTIN NEEDS FURTHER STUDY FOR LYMES DISEASE
2 August 1993
NEW LOMEFLOXACIN EFFICACY DATA
19 April 1993
GLAXO INTERIM PROFITS UP 16%
22 February 1993
ISRAEL CONSIDERS KORATH INCLUSIONS
4 January 1993
SB WINS QUEEN'S AWARD FOR BACTROBAN
27 April 1992
DRUG LISTING IN ISRAEL'S KORATH
16 March 1992
Showing 1-50 of 50 articles
- 1
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
